Literature DB >> 12600208

Bacterial expression and characterization of a novel, soluble, calcium-binding, and calcium-activated human nucleotidase.

Deirdre M Murphy1, Vasily V Ivanenkov, Terence L Kirley.   

Abstract

A newly discovered human analogue of a bed bug apyrase, which we named hSCAN-1 for human soluble calcium-activated nucleotidase-1, was expressed in bacteria, refolded from inclusion bodies, purified, and characterized. This apyrase, which is distinct from the eNTPDases exemplified by the endothelial CD39 (NTPDase1) apyrase, is a 38 kDa monomeric enzyme capable of hydrolyzing a variety of nucleoside di- and triphosphates, but not monophosphates. Preferred substrates include GDP, UDP, and IDP, with a pH optimum for activity between 6 and 7. The specific activity and substrate preference of the bacterially expressed enzyme closely mimic those of the enzyme expressed in mammalian COS cells, as well as the enzyme synthesized in an in vitro bacterial expression system. This suggests that glycosylation and other posttranslational modifications that do not occur in bacteria are not necessary for nucleotidase activity or proper folding of this human apyrase. hSCAN-1 absolutely requires Ca(2+), but not Mg(2+) or other divalent cations analyzed, for enzymatic activity. Surprisingly, the activity does not increase in a quasi-linear fashion at sub-millimolar Ca(2+) concentrations, as would be expected if Ca(2+) were only used as a cosubstrate for the nucleotide substrate, but rather follows a sigmoidal curve. The intrinsic fluorescence and difference absorption studies of hSCAN-1 in the absence of nucleotides revealed Ca(2+)-induced changes in the environment of tryptophan and tyrosine residues with half-saturation at about 90 microM Ca(2+). NaCl increased the half-saturating Ca(2+) concentration needed for both structural changes detected by optical spectroscopy and enzymatic activation of hSCAN-1 detected by nucleotidase assay. These results suggest that Ca(2+) triggers a conformational change in hSCAN-1, converting the enzymatically inactive protein to the active enzyme, in addition to forming the metal-nucleotide substrate complex necessary for nucleotidase activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600208     DOI: 10.1021/bi026763b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Ca2+-activated nucleotidase 1, a novel target gene for the transcriptional repressor DREAM (downstream regulatory element antagonist modulator), is involved in protein folding and degradation.

Authors:  Tito Calì; Laura Fedrizzi; Denis Ottolini; Rosa Gomez-Villafuertes; Britt Mellström; Jose R Naranjo; Ernesto Carafoli; Marisa Brini
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

2.  N-linked oligosaccharides affect the enzymatic activity of CD39: diverse interactions between seven N-linked glycosylation sites.

Authors:  James J Wu; Lisa E Choi; Guido Guidotti
Journal:  Mol Biol Cell       Date:  2005-01-26       Impact factor: 4.138

3.  The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro.

Authors:  Josefine Gerhardt; Corinna Steinbrech; Oralea Büchi; Silvia Behnke; Annette Bohnert; Florian Fritzsche; Heike Liewen; Frank Stenner; Peter Wild; Thomas Hermanns; Michael Müntener; Manfred Dietel; Klaus Jung; Carsten Stephan; Glen Kristiansen
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

4.  Characterization and importance of the dimer interface of human calcium-activated nucleotidase.

Authors:  Mingyan Yang; Katsunori Horii; Andrew B Herr; Terence L Kirley
Journal:  Biochemistry       Date:  2007-12-08       Impact factor: 3.162

5.  Functional characterization of a salivary apyrase from the sand fly, Phlebotomus duboscqi, a vector of Leishmania major.

Authors:  Ryoichi Hamasaki; Hirotomo Kato; Yoshimi Terayama; Hiroyuki Iwata; Jesus G Valenzuela
Journal:  J Insect Physiol       Date:  2009-08-11       Impact factor: 2.354

6.  Identification of CANT1 mutations in Desbuquois dysplasia.

Authors:  Céline Huber; Bénédicte Oulès; Marta Bertoli; Mounia Chami; Mélanie Fradin; Yasemin Alanay; Lihadh I Al-Gazali; Margreet G E M Ausems; Pierre Bitoun; Denise P Cavalcanti; Alexander Krebs; Martine Le Merrer; Geert Mortier; Yousef Shafeghati; Andrea Superti-Furga; Stephen P Robertson; Carine Le Goff; Andrea Onetti Muda; Patrizia Paterlini-Bréchot; Arnold Munnich; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

7.  Revelation of a catalytic calcium-binding site elucidates unusual metal dependence of a human apyrase.

Authors:  David W Rooklin; Min Lu; Yingkai Zhang
Journal:  J Am Chem Soc       Date:  2012-09-10       Impact factor: 15.419

8.  Incorporation of phosphate into glycogen by glycogen synthase.

Authors:  Christopher J Contreras; Dyann M Segvich; Krishna Mahalingan; Vimbai M Chikwana; Terence L Kirley; Thomas D Hurley; Anna A DePaoli-Roach; Peter J Roach
Journal:  Arch Biochem Biophys       Date:  2016-03-29       Impact factor: 4.013

9.  Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo.

Authors:  Mingyan Yang; Terence L Kirley
Journal:  Thromb Res       Date:  2008-01-28       Impact factor: 3.944

10.  Characterization of the ATP-hydrolysing activity of alpha-sarcoglycan.

Authors:  Dorianna Sandonà; Stefano Gastaldello; Tiziana Martinello; Romeo Betto
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.